柳杨 赵红喜

    [摘要] 目的 探讨辽宁中医药大学附属医院(以下简称“我院”)2014～2016年辅助用药使用情况，指导合理用药。 方法 对我院2014～2016年销售金额、用药频度(DDDs)排序前10位的辅助用药数据进行分析。 结果 2014～2016年我院销售金额排名前10位的均为注射剂和口服中成药，品种以神经营养类、心脑血管类、其他中成药类为主，使用科室以心血管内科、脑病康复科、神经内科为主；DDDs排名前10位的辅助用药中口服中成药排名较靠前；日均费用(DDC)较大的主要为注射剂，且它们的排序比(B/A)同步性不佳，价格较高；辅助用药不良反应(ADR)发生率较高，连续3年超过60%。 结论 我院辅助用药销售金额与DDDs同步性较好，但仍应注意辅助用药的过度使用，加强监控，促进合理用药。

    [关键词] 辅助用药；销售金额；用药频度；日均费用；不良反应

    [中图分类号] R969.3 [文献标识码] A [文章编号] 1673-7210(2018)03(c)-0130-04

    [Abstract] Objective To explore the condition of the use of adjuvant drugs in the Affiliated Hospital of Liaoning University of Traditional Chinese Medicine (hereinafter referred to as "our hospital") from 2014 to 2016， and to guide rational drug use. Methods The utilization of top 10 adjuvant drugs in the list of consumption sum and defined daily doses (DDDs) in our hospital from 2014 to 2016 were analyzed. Results From 2014 to 2016， the top 10 adjuvant drugs in the list of consumption sum were injections and oral Chinese patent medicines， the varieties were mainly composed of neurotrophic， cardio-cerebrovascular drugs and other Chinese patent medicines. Drugs were more used in the department of cardiovascular medicine ......